AAAAAA

   
Results: 1-10 |
Results: 10
Inactivation of infectious pathogens in labile blood components: meeting the challenge
Authors: Corash, L
Citation: L. Corash, Inactivation of infectious pathogens in labile blood components: meeting the challenge, TRANSF CL B, 8(3), 2001, pp. 138-145
Design of clinical trials to evaluate the efficacy of platelet transfusion: The euroSPRITE trial for components treated with Helinx (TM) technology
Authors: Cazenave, JP Davis, K Corash, L
Citation: Jp. Cazenave et al., Design of clinical trials to evaluate the efficacy of platelet transfusion: The euroSPRITE trial for components treated with Helinx (TM) technology, SEM HEMATOL, 38(4), 2001, pp. 46-54
New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes
Authors: Corash, L
Citation: L. Corash, New technologies for the inactivation of infectious pathogens in cellular blood components and the development of platelet substitutes, BEST P R C, 13(4), 2000, pp. 549-563
Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats
Authors: van Rhenen, DJ Vermeij, J Mayaudon, V Hind, C Lin, D Corash, L
Citation: Dj. Van Rhenen et al., Functional characteristics of S-59 photochemically treated platelet concentrates derived from buffy coats, VOX SANGUIN, 79(4), 2000, pp. 206-214
Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function
Authors: Knutson, F Alfonso, R Dupuis, K Mayaudon, V Lin, L Corash, L Hogman, CF
Citation: F. Knutson et al., Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function, VOX SANGUIN, 78(4), 2000, pp. 209-216
Inactivation of infectious pathogens and leukocytes in platelet concentrates
Authors: Corash, L
Citation: L. Corash, Inactivation of infectious pathogens and leukocytes in platelet concentrates, PLATELET THERAPY: CURRENT STATUS AND FUTURE TRENDS, 2000, pp. 439-466
Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives
Authors: Corash, L
Citation: L. Corash, Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives, TR MED REV, 13(1), 1999, pp. 18-30
Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution
Authors: Davis, KB Slichter, SJ Corash, L
Citation: Kb. Davis et al., Corrected count increment and percent platelet recovery as measures of posttransfusion platelet response: problems and a solution, TRANSFUSION, 39(6), 1999, pp. 586-592
Elimination of cytokine production in stored platelet concentrate aliquotsby photochemical treatment with psoralen plus ultraviolet A light
Authors: Hei, DJ Grass, J Lin, L Corash, L Cimino, G
Citation: Dj. Hei et al., Elimination of cytokine production in stored platelet concentrate aliquotsby photochemical treatment with psoralen plus ultraviolet A light, TRANSFUSION, 39(3), 1999, pp. 239-248
Prevention of transfusion-associated graft-versus-host disease by photochemical treatment
Authors: Grass, JA Wafa, T Reames, A Wages, D Corash, L Ferrara, JLM Lin, L
Citation: Ja. Grass et al., Prevention of transfusion-associated graft-versus-host disease by photochemical treatment, BLOOD, 93(9), 1999, pp. 3140-3147
Risultati: 1-10 |